Prostate Cancer - Results from #26280

Significant addition to treatment options for bone metastasis in prostate cancer - Abstract April 5, 2012

Rescue cryotherapy for prostate cancer after radiotherapy - Abstract April 5, 2012

Prostate Specific Antigen (PSA), yet how much damage? - Abstract April 5, 2012

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? - Abstract April 5, 2012

Sipuleucel-T for the treatment of metastatic prostate cancer: Promise and challenges - Abstract April 5, 2012

Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer - Abstract April 5, 2012

Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer - Abstract April 5, 2012

Single-port laparoscopic radical prostatectomy: Initial experience and technical points to reduce its difficulties April 5, 2012

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer - Abstract April 4, 2012

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group - Abstract April 4, 2012

Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy - Abstract April 4, 2012

Association between smoking status, and free, total and percent free prostate specific antigen - Abstract April 4, 2012

Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment - Abstract April 4, 2012

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study - Abstract April 4, 2012

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism - Abstract April 4, 2012

Active surveillance versus surgery for low risk prostate cancer: A clinical decision analysis - Abstract April 4, 2012

Management of prostate cancer biochemical recurrence in the clinical guidelines - Abstract April 4, 2012

Hormone therapy for prostate cancer April 4, 2012

Epidemiology April 3, 2012

Prostate Cancer Natural History April 3, 2012

Page 1315 of 1447